| Financial Year |
March 31 2023 |
| Monetary Funds |
60,752,002.64 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
631,670.08 |
| Accounts Receivable |
382,987,427.31 |
| Advances to Suppliers |
16,331,455.40 |
| Other Receivables |
312,299,282.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
35,322,258.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,791,396.34 |
| Total Current Assets |
1,029,828,234.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
149,248,129.76 |
| Fixed Assetes |
328,152,396.51 |
| Under-construction Projects |
2,362,302.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
344,290,621.06 |
| R&D expenses |
25,034,598.44 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,143,634.40 |
| Deferred Income Tax Assets |
3,614,623.88 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
869,010,768.46 |
| Total Assets |
1,898,839,002.58 |
| Short-Term Loans |
7,140,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
25,930,280.57 |
| Accounts Payable |
314,165,718.86 |
| Accounts Received In Advance |
1,660,428.71 |
| Employee Compensation Payable |
40,272,803.64 |
| Taxes Payable |
55,905,151.02 |
| Interest Payable |
158,064.53 |
| Dividend Payable |
-- |
| Other payables |
58,496,204.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
111,495,369.64 |
| Other Current Liabilities |
2,247,586.82 |
| Sub-Total of Current Liabilities |
700,415,484.16 |
| Long-term Loans |
385,313,662.29 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,900,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
417,317,965.52 |
| Total Liabilities |
1,117,733,449.68 |
| Paid-In Capital(Or Share Stock) |
770,161,228.00 |
| Capital Surplus |
973,513,255.47 |
| Surplus Reserve |
42,723,544.56 |
| LESS:Treasury Stock |
23,811,240.00 |
| Undistributed Profits |
-977,684,589.65 |
| Minority Stockholder's Interest |
-2,044,941.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
783,150,494.80 |
| Owner's Equity（Stockholder's Equity） |
781,105,552.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,898,839,002.58 |
